Literature DB >> 16328565

Retrospective multicentric study of pituitary incidentalomas.

Patricia Fainstein Day1,2, Mirtha Guitelman3, Rosa Artese3, León Fiszledjer3, Alberto Chervin3, Nicolás Marcelo Vitale3, Graciela Stalldecker3, Valeria De Miguel3, Dora Cornaló3, Analía Alfieri3, María Susana3, Mallea Gil3.   

Abstract

Previously unsuspected pituitary tumors (incidentalomas) were analyzed in autopsies (4.8-27%) and magnetic resonance imaging (MRI) (10-37%), most of them being micro-pituitary incidentalomas (PI). However, patients with PIs sometimes had macroadenomas which may relate to previously unsuspected neurological and/or endocrine abnormalities. This study aims to establish the incidence of macro- vs. micro-PIs, the need for medical and/or surgical treatment and the neurological and endocrine dysfunction in a retrospective evaluation of patients with PIs studied over six years (1994-2000). Thirty-eight of 46 patients with PIs (22 males), aged 16-77, were followed for a mean of 3.2 years. Initial hormonal testing, ophthalmologic evaluation and MRI were repeated during follow-up. Twenty-nine (63%) of 46 patients had macro-PIs and 17 (17%) micro-PIs. Twenty-three males (75%) had macro-PIs, 10 (34.5%) with visual field defects. Consultations leading to PI diagnosis were chronic headache (28%), cranial trauma (15.3%), sinusitis (13%) and stroke (13%). Partial deficiencies of the anterior pituitary function were confirmed in 19 PIs (41.3%), with secondary hypogonadism prevailing (30%). Seven PIs (15%) were prolactinomas treated with dopamine agonists. Seventeen PIs (37%) underwent surgery. Immunohistochemical analysis showed gonadotrophinomas (30%), plurihormonal non-secreting adenomas (40%), and pituitary adenomas not reacting to any of the anterior pituitary hormone antibodies (30%). One operated macro-PI was a craniopharyngioma. Our data show a high percentage of PIs are macro-incidentalomas against expectations from necropsy and imaging studies. Most macro-PIs are found in males and are clinically non-functioning adenomas, 37% requiring surgery and hormonal substitution.

Entities:  

Mesh:

Year:  2004        PMID: 16328565     DOI: 10.1007/s11102-005-1757-1

Source DB:  PubMed          Journal:  Pituitary        ISSN: 1386-341X            Impact factor:   4.107


  15 in total

Review 1.  The pituitary "incidentaloma".

Authors:  M E Molitch; E J Russell
Journal:  Ann Intern Med       Date:  1990-06-15       Impact factor: 25.391

Review 2.  Clinical-pathological correlations of pituitary tumours.

Authors:  K Thapar; K Kovacs; P J Muller
Journal:  Baillieres Clin Endocrinol Metab       Date:  1995-04

3.  Regions of low density in the contrast-enhanced pituitary gland: normal and pathologic processes.

Authors:  E F Chambers; P A Turski; D LaMasters; T H Newton
Journal:  Radiology       Date:  1982-07       Impact factor: 11.105

4.  Intracranial pearly tumors: the roles of computed tomography, angiography, and pneumoencephalography.

Authors:  M A Mikhael; A G Mattar
Journal:  J Comput Assist Tomogr       Date:  1978-09       Impact factor: 1.826

5.  Incidentally discovered pituitary lesions: high frequency of macroadenomas and hormone-secreting adenomas - results of a prospective study.

Authors:  J Feldkamp; R Santen; E Harms; A Aulich; U Mödder; W A Scherbaum
Journal:  Clin Endocrinol (Oxf)       Date:  1999-07       Impact factor: 3.478

6.  Therapeutic strategy for incidentally found pituitary tumors ("pituitary incidentalomas").

Authors:  S Nishizawa; S Ohta; T Yokoyama; K Uemura
Journal:  Neurosurgery       Date:  1998-12       Impact factor: 4.654

7.  Incidental pituitary lesions in 1,000 unselected autopsy specimens.

Authors:  A Teramoto; K Hirakawa; N Sanno; Y Osamura
Journal:  Radiology       Date:  1994-10       Impact factor: 11.105

8.  Pituitary magnetic resonance imaging in normal human volunteers: occult adenomas in the general population.

Authors:  W A Hall; M G Luciano; J L Doppman; N J Patronas; E H Oldfield
Journal:  Ann Intern Med       Date:  1994-05-15       Impact factor: 25.391

Review 9.  Clinical review 65. Evaluation and treatment of the patient with a pituitary incidentaloma.

Authors:  M E Molitch
Journal:  J Clin Endocrinol Metab       Date:  1995-01       Impact factor: 5.958

10.  Galactorrhea: a study of 235 cases, including 48 with pituitary tumors.

Authors:  D L Kleinberg; G L Noel; A G Frantz
Journal:  N Engl J Med       Date:  1977-03-17       Impact factor: 91.245

View more
  24 in total

1.  Spontaneous regression of one nonfunctioning pituitary macroadenoma associated with abnormal liver enzyme tests.

Authors:  Adele Bahar; Zahra Kashi; Arezoo Nowzari
Journal:  Caspian J Intern Med       Date:  2011

2.  Clinical Course of Nonfunctional Pituitary Microadenoma in Children: A Single-Center Experience.

Authors:  Vidhu V Thaker; Adrianne E Lage; Garima Kumari; V Michelle Silvera; Laurie E Cohen
Journal:  J Clin Endocrinol Metab       Date:  2019-12-01       Impact factor: 5.958

Review 3.  Subclinical hyperfunctioning pituitary adenomas: the silent tumors.

Authors:  Odelia Cooper; Shlomo Melmed
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2012-05-22       Impact factor: 4.690

Review 4.  Epidemiology, clinical presentation and diagnosis of non-functioning pituitary adenomas.

Authors:  Georgia Ntali; John A Wass
Journal:  Pituitary       Date:  2018-04       Impact factor: 4.107

Review 5.  Endocrine incidentalomas--challenges imposed by incidentally discovered lesions.

Authors:  Dimitra A Vassiliadi; Stylianos Tsagarakis
Journal:  Nat Rev Endocrinol       Date:  2011-06-28       Impact factor: 43.330

Review 6.  Pituitary incidentalomas.

Authors:  George A Scangas; Edward R Laws
Journal:  Pituitary       Date:  2014-10       Impact factor: 4.107

Review 7.  Management of nonfunctioning pituitary adenomas (NFAs): observation.

Authors:  Wenyu Huang; Mark E Molitch
Journal:  Pituitary       Date:  2018-04       Impact factor: 4.107

8.  A prospective study of nonfunctioning pituitary adenomas: presentation, management, and clinical outcome.

Authors:  Lukui Chen; William L White; Robert F Spetzler; Bainan Xu
Journal:  J Neurooncol       Date:  2010-08-21       Impact factor: 4.130

Review 9.  Pituitary Dysfunction Among Men Presenting with Hypogonadism.

Authors:  Shiri Levy; Mingxue Arguello; Mohamed Macki; Sudhaker D Rao
Journal:  Curr Urol Rep       Date:  2019-11-16       Impact factor: 3.092

10.  Dopamine agonist therapy induces significant recovery of HPA axis function in prolactinomas independent of tumor size: a large single center experience.

Authors:  Christine G Yedinak; Isabelle Cetas; Alp Ozpinar; Shirley McCartney; Aclan Dogan; Maria Fleseriu
Journal:  Endocrine       Date:  2016-07-26       Impact factor: 3.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.